PlainPharmaWatch

CMS Open Payments · Tool

O&M Halyard, Inc. vs Colgate Oral Pharmaceuticals, Inc.

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

O&M Halyard, Inc. has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 10,000, versus 64 for the other company. Its single largest recorded recipient represents 100.0% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

O&M Halyard, Inc.
HHI 10,000 · top recipient 100.0%
Ranked #130 of 1,838 companies by HHI
Colgate Oral Pharmaceuticals, Inc.
HHI 64 · top recipient 4.4%
Ranked #1,744 of 1,838 companies by HHI

Payment Overview

Company A

O&M Halyard, Inc.

Total Payments
$239.1K
% of Industry
0.0%
Transactions
11
Avg per Transaction
$21.7K
Recipients
11
Avg per Recipient
$21.7K
Payment Types
1
Top Payment Type
Consulting Fee
Total Payments
$238.5K
% of Industry
0.0%
Transactions
6,976
Avg per Transaction
$34.19
Recipients
6,976
Avg per Recipient
$34.19
Payment Types
6
Top Payment Type
Education

Highlighted values indicate the higher figure for each metric.

Total payments compared

O&M Halyard, Inc. vs Colgate Oral Pharmaceuticals, Inc. - total reported payments in CMS Open Payments PY2024

O&M Halyard, Inc.$239.1KColgate Oral Pharmaceutical…$238.5K

General Payment Types Breakdown

Category shares use each company's General Payments total, not the all-tracks (General + Research + Ownership) hero figure.

O&M Halyard, Inc.

Consulting Fee $239.1K

100.0%

Colgate Oral Pharmaceuticals, Inc.

Education $157.0K

65.8%

Compensation for Services Other Than Consulting $39.1K

16.4%

Food and Beverage $18.3K

7.7%

Consulting Fee $17.5K

7.3%

Travel and Lodging $5.1K

2.1%

Compensation for Faculty or Speaker (Medical Education) $1.5K

0.6%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

O&M Halyard, Inc.

  1. 1

    Laurent Dreyfuss

    $239,050.00 · 11 txns

Colgate Oral Pharmaceuticals, Inc.

  1. 1

    RYAN SAVAGE

    $10,549.94 · 4 txns

  2. 2

    FRANK CASTILLO

    $8,803.60 · 8 txns

  3. 3

    SHEILA DOBEE

    $6,337.74 · 6 txns

  4. 4

    JAMES ALBRECHT

    $5,981.83 · 6 txns

  5. 5

    AHAD SAQIB

    $5,877.29 · 7 txns

Summary Comparison

Metric O&M Halyard, Inc. Colgate Oral Pharmaceuticals, Inc.
Total Payments $239.1K $238.5K
% of Industry Total 0.0% 0.0%
Transaction Count 11 6,976
Avg per Transaction $21.7K $34.19
Recipient Count 11 6,976
Avg per Recipient $21.7K $34.19
Payment Type Count 1 6
Top Payment Type Consulting Fee Education

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.